EAM
Exane Asset Management’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-50,013
| Closed | -$3.38M | – | 37 |
|
|
2019
Q2 | $3.38M | Buy |
50,013
+2,013
| +4% | +$136K | 1.5% | 23 |
|
|
2019
Q1 | $3.12M | Buy |
48,000
+26,169
| +120% | +$1.7M | 1.52% | 23 |
|
|
2018
Q4 | $1.37M | Sell |
21,831
-162,624
| -88% | -$10.2M | 0.8% | 24 |
|
|
2018
Q3 | $14.2M | Buy |
184,455
+166,055
| +902% | +$12.8M | 4.46% | 6 |
|
|
2018
Q2 | $1.3M | Sell |
18,400
-14,654
| -44% | -$1.04M | 0.56% | 32 |
|
|
2018
Q1 | $2.49M | Sell |
33,054
-249,492
| -88% | -$18.8M | 0.75% | 27 |
|
|
2017
Q4 | $20.2M | Sell |
282,546
-277,041
| -50% | -$19.8M | 6.29% | 7 |
|
|
2017
Q3 | $45.3M | Buy |
559,587
+225,985
| +68% | +$18.3M | 8.86% | 1 |
|
|
2017
Q2 | $23.6M | Buy |
333,602
+74,982
| +29% | +$5.31M | 7.36% | 3 |
|
|
2017
Q1 | $17.6M | Buy |
258,620
+8,331
| +3% | +$566K | 5.45% | 7 |
|
|
2016
Q4 | $17.9M | Sell |
250,289
-7,470
| -3% | -$535K | 5.9% | 6 |
|
|
2016
Q3 | $20.4M | Buy |
257,759
+66,804
| +35% | +$5.29M | 6.39% | 2 |
|
|
2016
Q2 | $15.9M | Buy |
190,955
+190,782
| +110,279% | +$15.9M | 6.18% | 5 |
|
|
2016
Q1 | $15.9K | Sell |
173
-80,623
| -100% | -$7.41M | 0.01% | 24 |
|
|
2015
Q4 | $8.18M | Buy |
+80,796
| New | +$8.18M | 4.96% | 7 |
|